The Lynx Group
Cholangiocarcinoma News

Conversations on Cholangiocarcinoma

The Role of FGFR Inhibitors in Treating FGFR2 Fusion–Positive Cholangiocarcinoma
Videos — February 22, 2021
Drs Javle and Hollebecque review the phase 2 clinical trial efficacy data of pemigatinib, infigratinib, and futibatinib as second-line therapy of FGFR2 fusion–positive cholangiocarcinoma, and explore use of these agents in the first-line and adjuvant settings.
Read More

The Role of FGFR Genetic Alterations in Cholangiocarcinoma
Videos — January 21, 2021
A discussion of the molecular biology of the FGFR pathway in the growth and development of cholangiocarcinoma.
Read More

Subscribe to CCA News

Stay up to date with personalized medicine by subscribing to recieve the free CCA News print publication or weekly e‑Newsletter.

I'd like to recieve: